Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:SHR
日付受信時刻ニュースソース見出しコード企業名
2007/01/1917 : 20PR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/12/0522 : 25PR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/11/2817 : 45PR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingNYSE:SHR
2006/11/2716 : 33PR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006NYSE:SHR
2006/11/2502 : 25PR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/11/2318 : 40PR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisNYSE:SHR
2006/11/0815 : 54PR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/10/3122 : 00PR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaNYSE:SHR
2006/10/3104 : 10PR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/10/2323 : 39PR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisNYSE:SHR
2006/10/1722 : 47PR Newswire (US)Family Planning Programs in the Fight Against PovertyNYSE:SHR
2006/10/0521 : 30PR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)NYSE:SHR
2006/09/1916 : 58PR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyNYSE:SHR
2006/09/1823 : 01PR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombNYSE:SHR
2006/09/1517 : 32PR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugNYSE:SHR
2006/09/1423 : 00PR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityNYSE:SHR
2006/09/1421 : 48PR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaNYSE:SHR
2006/09/1319 : 32PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/09/0420 : 19PR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandNYSE:SHR
2006/09/0123 : 00PR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/08/3019 : 13PR Newswire (US)Group Environmental Report for 2006 PublishedNYSE:SHR
2006/08/1700 : 50PR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/08/0417 : 15PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andNYSE:SHR
2006/08/0223 : 00PR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningNYSE:SHR
2006/07/3123 : 49PR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLNYSE:SHR
2006/07/3123 : 36PR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsNYSE:SHR
2006/07/3123 : 21PR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlNYSE:SHR
2006/07/3123 : 20PR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
2006/07/2703 : 46PR Newswire (US)KPMG Values Schering AG Share at EUR 87.63NYSE:SHR
2006/07/2516 : 28PR Newswire (US)Schering AG Raises Outlook After Strong First Half YearNYSE:SHR
 Showing the most relevant articles for your search:NYSE:SHR

最近閲覧した銘柄

Delayed Upgrade Clock